Rifaximin for bloating in functional bowel disorders
Treatments studied
Part of Digestive system clinical trials.
This study tests whether rifaximin, an antibiotic that works in the gut, can reduce bloating in people with irritable bowel syndrome, constipation, or functional bloating. Rifaximin may help by changing the balance of bacteria in your intestines.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 80 years old
- You have been diagnosed with IBS, functional constipation, or functional bloating using Rome IV criteria (a standardized diagnostic method)
- You experience bothersome bloating that is at least moderate in severity, and your bowel movements are now regular (3 times per week to 3 times per day) after treatment for constipation
- You have had a colonoscopy, CT scan, or barium X-ray of your colon as part of your standard care
- You are willing and able to stop certain medications (antibiotics, acid-reducers, probiotics, NSAIDs, and others) that could interfere with the study
- You do not have inflammatory bowel disease, major prior bowel surgery, or a known allergy to rifaximin
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests if adding the gut antibiotic rifaximin to ticagrelor (a blood thinner) can further reduce the risk of blood clots in people who've had a heart attack. It's for patients whose platelets are still too active despite taking ticagrelor.
This trial tests whether a diet low in certain hard-to-digest carbohydrates (called FODMAPs) can reduce bloating in people with Irritable Bowel Syndrome (IBS) or chronic constipation with bloating. Participants will receive either a low FODMAP diet or a control diet for a period to see which helps more.
This trial tests if adding the drug Rifaximin can help prevent diarrhea caused by radiation therapy for pelvic cancers. It may be an option for people starting radiation or chemoradiation for non-metastatic pelvic cancer.
This study tests whether the antibiotic rifaximin can relieve bloating in people with small intestinal bacterial overgrowth (SIBO). If you have chronic bloating and a positive SIBO breath test, this trial may be a good fit.
This trial looks at whether an overgrowth of bacteria in the small intestine causes bloating. It tests how well treatment works for people with functional bloating (bloating without a clear cause) who also have this bacterial overgrowth.
This study tests how Rifaximin (a medicine for SIBO) affects the bacteria and other substances in your gut. You'll swallow a small capsule that collects samples as it travels through your digestive system, so researchers can see how your gut changes during treatment.
Hear when a new Bloating trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.